C92.92
C92.92: Myeloid leukemia, unspecified in relapse
Billable / specific codeICD-10-CM
C92.92 is a billable, specific ICD-10-CM code for myeloid leukemia, unspecified in relapse. It is valid for submission on a claim.
Check C92.92 with the rest of the claim: free scrubberOther codes that can never be billed with C92.92
Their own Excludes1 notes name this code, so the conflict is not listed above.
- D72.825Bandemia
Risk adjustment
C92.92 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 20 Lung and Other Severe Cancers1.136 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score. Look up the whole chart to see which of its HCCs the hierarchy would zero.
Medicare coverage
C92.92 is named in 44 Medicare coverage policies: 44 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.
- A52479Oral Anticancer Drugs - Policy Article
- A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
- A54768Billing and Coding: Cardiac Blood Pool Imaging (Multiple Gated Acquisition Scanning- MUGA, Ventriculography) When Performed in Conjunction with Cardiotoxic Chemotherapy
- A55717Billing and Coding: Lab: Flow Cytometry
Code history
Unchanged in every release from FY2024 to FY2027.